|
Mean ± SD metabolic parameters at baseline and end of treatment |
||||||
| Baseline |
p value |
End of treatment |
p value |
|||
|
|
||||||
| Losartan |
Telmisartan |
Losartan |
Telmisartan |
|||
|
|
||||||
| HOMA-IR |
5.78 ± 3.53 |
5.74 ± 3.35 |
NS |
5.82 ± 2.66 |
4.24 ± 2.36 |
< 0.05 |
| FPG |
110.05 ± 14.56 |
109.08 ± 16.67 |
NS |
113.20 ± 12.68 |
100.00 ± 11.99 |
< 0.05 |
| FPI |
20.47 ± 9.64 |
18.86 ± 10.89 |
NS |
20.14 ± 9.49 |
16.93 ± 8.91 |
< 0.06 |
| 2-hour OGTT |
137.42 ± 32.5 |
131.31 ± 42.05 |
NS |
134.6 ± 26.71 |
113.85 ± 42.14 |
< 0.01 |
| HbA1c |
6.27 ± 0.29 |
6.45 ± 0.35 |
NS |
6.28 ± 0.21 |
5.85 ± 0.18 |
< 0.05 |
Vitale et al. Cardiovascular Diabetology 2005 4:6 doi:10.1186/1475-2840-4-6 |
||||||